Article Information
History
- December 19, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- 1Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- 2Medical-Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- 3Institute for Computational Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America
- 4Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, United States of America
- 5Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- 6Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America
- 7Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, Maryland, United States of America
- 8Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, Maryland, United States of America
- 9Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America
- 10Institute for Nano Biotechnology (INBT), Johns Hopkins University, Baltimore, Maryland, United States of America
- ↵*Corresponding author E-mail: christyray{at}jhmi.edu (CMPR)
Posted December 19, 2023.
Mechanistic computational modeling of monospecific and bispecific antibodies targeting interleukin-6/8 receptors
